SOUTH SAN FRANCISCO, Calif, April 25, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (CERO), (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback